Want to see COLL full AI Analyst Report?
Total Valuation
Collegium Pharmaceutical has a market cap or net worth of $836.68M. The enterprise value is $2.24K.
Market Cap$836.68M
Enterprise Value$2.24K
Share Statistics
Collegium Pharmaceutical has 32,555,614 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding32,555,614
Owned by Insiders12.92%
Owned by Institutions13.19%
Financial Efficiency
Collegium Pharmaceutical’s return on equity (ROE) is 0.21 and return on invested capital (ROIC) is 10.18%.
Return on Equity (ROE)0.21
Return on Assets (ROA)0.04
Return on Invested Capital (ROIC)10.18%
Return on Capital Employed (ROCE)0.15
Revenue Per Employee1.85M
Profits Per Employee148.63K
Employee Count423
Asset Turnover0.47
Inventory Turnover7.76
Valuation Ratios
The current PE Ratio of Collegium Pharmaceutical is 18.4. Collegium Pharmaceutical’s PEG ratio is -3.13.
PE Ratio18.4
PS Ratio1.88
PB Ratio4.87
Price to Fair Value4.87
Price to FCF4.48
Price to Operating Cash Flow2.77
PEG Ratio-3.13
Income Statement
In the last 12 months, Collegium Pharmaceutical had revenue of 780.57M and earned 62.87M in profits. Earnings per share was 1.98.
Revenue780.57M
Gross Profit463.26M
Operating Income187.08M
Pretax Income92.62M
Net Income62.87M
EBITDA401.00M
Earnings Per Share (EPS)1.98
Cash Flow
In the last 12 months, operating cash flow was 329.92M and capital expenditures -1.64M, giving a free cash flow of 328.28M billion.
Operating Cash Flow329.92M
Free Cash Flow328.28M
Free Cash Flow per Share10.08
Dividends & Yields
Collegium Pharmaceutical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.35
52-Week Price Change-24.25%
50-Day Moving Average34.26
200-Day Moving Average39.15
Relative Strength Index (RSI)33.44
Average Volume (3m)420.68K
Important Dates
Collegium Pharmaceutical upcoming earnings date is Nov 5, 2026, TBA (Confirmed).
Last Earnings DateAug 6, 2026
Next Earnings DateNov 5, 2026
Ex-Dividend Date―
Financial Position
Collegium Pharmaceutical as a current ratio of 1.57, with Debt / Equity ratio of 275.01%
Current Ratio1.57
Quick Ratio1.48
Debt to Market Cap0.64
Net Debt to EBITDA1.72
Interest Coverage Ratio2.27
Taxes
In the past 12 months, Collegium Pharmaceutical has paid 29.75M in taxes.
Income Tax29.75M
Effective Tax Rate0.32
Enterprise Valuation
Collegium Pharmaceutical EV to EBITDA ratio is 5.38, with an EV/FCF ratio of 6.59.
EV to Sales2.76
EV to EBITDA5.38
EV to Free Cash Flow6.59
EV to Operating Cash Flow6.55
Balance Sheet
Collegium Pharmaceutical has $129.47M in cash and marketable securities with $857.79M in debt, giving a net cash position of -$728.33M billion.
Cash & Marketable Securities$129.47M
Total Debt$857.79M
Net Cash-$728.33M
Net Cash Per Share-$22.37
Tangible Book Value Per Share-$16.20
Margins
Gross margin is 60.02%, with operating margin of 23.97%, and net profit margin of 8.05%.
Gross Margin60.02%
Operating Margin23.97%
Pretax Margin11.87%
Net Profit Margin8.05%
EBITDA Margin51.37%
EBIT Margin22.41%
Analyst Forecast
The average price target for Collegium Pharmaceutical is $51.25, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$51.25
Price Target Upside45.60% Upside
Analyst ConsensusStrong Buy
Analyst Count4
Revenue Growth Forecast14.31%
EPS Growth Forecast34.35%